Related Experiment Videos
A Primer on Detecting Cirrhosis and Caring for These Patients without Causing Harm
1Department of Internal Medicine, Division of Gastroenterology/Hepatology, Loma Linda University Medical Center, 11234 Anderson Street, Room 1556, Loma Linda, CA 92354, USA.
Many cirrhosis patients are undiagnosed and vulnerable to harm from common treatments. This paper offers guidance on safe care, medications, and procedures for fragile patients with liver disease.
Area of Science:
- Hepatology
- Internal Medicine
- Patient Safety
Background:
- Undiagnosed cirrhosis is common, leading to severe complications like multiorgan failure after procedures.
- Cirrhosis patients are highly susceptible to iatrogenic harm from medications and interventions.
- Clinical practice lacks clear guidelines for managing patients with cirrhosis.
Purpose of the Study:
- To provide practical advice for identifying and managing patients with cirrhosis.
- To clarify safe medication use, dietary recommendations, and procedural risks for cirrhosis patients.
- To reduce confusion and improve patient safety in liver disease care.
Main Methods:
- Review of clinical experience over 30 years in a liver-failure practice.
- Synthesis of expert recommendations on cirrhosis patient management.
- Identification of diagnostic clues and management "dos and do nots".
Main Results:
- Highlights subtle signs for diagnosing cirrhosis.
- Details safe and contraindicated medications for pain and sedation.
- Advises on appropriate diet and safe invasive procedures.
- Emphasizes the fragility of cirrhosis patients.
Conclusions:
- Early identification and cautious management are crucial for preventing complications in cirrhosis patients.
- Clear guidelines on medication, diet, and procedures can significantly improve outcomes.
- Expert-guided care is essential for this vulnerable population.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...